Mark J Ricciardi Selected Research

Mark J Ricciardi Research Topics

5	Heart Failure 01/2022 - 11/2012
4	Stroke (Strokes) 10/2019 - 01/2016
4	Myocardial Infarction 01/2017 - 10/2003
3	Cardiogenic Shock 12/2022 - 01/2018
3	ST Elevation Myocardial Infarction 01/2021 - 08/2008
3	Aortic Valve Stenosis (Aortic Stenosis) 10/2019 - 01/2019
2	Hemorrhage 03/2022 - 01/2016
2	Peripheral Arterial Disease 03/2022 - 12/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 03/2022 - 03/2003
2	Pathologic Constriction (Stenosis) 01/2018 - 09/2003
1	Ventricular Septal Rupture 01/2021
1	COVID-19 01/2021
1	Atrial Fibrillation 10/2019
1	Renal Insufficiency (Renal Failure) 10/2019
1	Aortic Dissection 07/2019
1	Dyspnea (Shortness of Breath) 06/2019
1	Cyanosis 06/2019
1	Pulmonary Hypertension 06/2019
1	Hematoma 01/2018
1	Delirium 06/2017
1	Emergence Delirium 06/2017
1	Acute Kidney Injury (Acute Renal Failure) 01/2017
1	Coronary Artery Disease (Coronary Atherosclerosis) 12/2016
1	Carotid Stenosis (Carotid Artery Stenosis) 12/2016
1	Frailty 01/2016
1	Respiratory Insufficiency (Respiratory Failure) 01/2016
1	Vascular System Injuries 01/2016
1	Cardiomyopathies (Cardiomyopathy) 06/2014
1	Unstable Angina 11/2012
1	Spasm (Spasms) 09/2012
1	Acquired Immunodeficiency Syndrome (AIDS) 09/2012
1	Thrombosis (Thrombus) 05/2007
1	Infarction (Infarctions) 04/2004
1	Ischemia 03/2003

3	salicylhydroxamic acid (SHAM)IBA 01/2022 - 01/2018
2	omega-Chloroacetophenone (Mace)IBA 03/2022 - 03/2003
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2022
1	high fluorescent intermediate IIIBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	N(2)-(3-trifluoromethylphenyl)guanineIBA 04/2004
1	MB 3 (MB-3)IBA 04/2004
1	Glycoproteins (Glycoprotein)IBA 10/2003
1	Tirofiban (Aggrastat)FDA Link 10/2003
1	Phenobarbital (Luminal)FDA Link 09/2003
1	TroponinIBA 03/2003
1	Troponin IIBA 03/2003
1	MB Form Creatine KinaseIBA 03/2003
1	IsoenzymesIBA 03/2003

6	Transcatheter Aortic Valve Replacement 10/2019 - 01/2016
4	Therapeutics 01/2021 - 06/2014
3	Catheters 01/2021 - 09/2012
3	Stents 06/2019 - 05/2007
3	Percutaneous Coronary Intervention 12/2016 - 03/2003
2	Length of Stay 06/2017 - 01/2016
1	Extracorporeal Membrane Oxygenation 12/2022
1	Secondary Prevention 03/2022
1	General Anesthesia 10/2019
1	Blood Transfusion (Blood Transfusions) 10/2019
1	Prostheses and Implants (Prosthesis) 07/2019
1	Septal Occluder Device 06/2019
1	Cannula 01/2018
1	Heart-Assist Devices 01/2018
1	Microbubbles 12/2016
1	Investigational Therapies (Experimental Therapy) 12/2016
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2016
1	Patient Readmission 11/2012
1	Ischemic Postconditioning 08/2008